DexCom (DXCM) PT Raised to $125 at Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
DexCom Executive Chairman and Director Terry Gregg Retires
August 1, 2018 4:10 PM EDTPresident and CEO Kevin Sayer Appointed Chairman of the Board
SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the leader in continuous glucose... More
DexCom Reports Second Quarter 2018 Financial Results
August 1, 2018 4:01 PM EDTSAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended June 30, 2018.
Second Quarter 2018 Highlights:
Revenue grew 42% to $242.5 million versus the same quarter of the prior year US revenue grew 35% versus the same quarter of the prior year International revenue grew 78% on a reported basis versus the same quarter of the prior year GAAP net income of $30.2 million, or $0.34 per share... More